Figure EV1. Luminescence mediated by recombinant AAV2 vectors displaying brain‐targeted peptides that were enriched by in vivo screening of a random AAV display peptide library.

Tissues were analyzed 28 days after tail vein injection of vectors harboring the luciferase gene under the control of the CMV promoter (5 × 10¹⁰ genomic particles/mouse, age 8–12 weeks). Luminescence was normalized to total protein content in the tissue lysates. Data are shown as bars (mean) with plotted individual data points (n = 3 animals/group).